Medicine

E. Rayburn, Scharri J. Ezell, Ruiwen Zhang

2009Molecular and Cellular Pharmacology

DOI: 10.4255/mcpharmacol.09.05

tlooto Summary

The relationship between inflammation and cancer with an emphasis on epidemiological evidence is explored, the current use of anti-inflammatory agents for cancer prevention and therapy is summarized, and the mechanisms underlying the anti-cancer effects ofAnti- inflammatory agents are described.

Abstract

Inflammation is closely linked to cancer, and many anti-cancer agents are also used to treat inflammatory diseases, such as rheumatoid arthritis. Moreover, chronic inflammation increases the risk for various cancers, indicating that eliminating inflammation may represent a valid strategy for cancer prevention and therapy. This article explores the relationship between inflammation and cancer with an emphasis on epidemiological evidence, summarizes the current use of anti-inflammatory agents for cancer prevention and therapy, and describes the mechanisms underlying the anti-cancer effects of anti-inflammatory agents. Since monotherapy is generally insufficient for treating cancer, the combined use of anti-inflammatory agents and conventional cancer therapy is also a focal point in discussion. In addition, we also briefly describe future directions that should be explored for anti-cancer anti-inflammatory agents.

Citation format

RAYBURN, E.; EZELL, Scharri J.; ZHANG, Ruiwen. Anti-inflammatory agents for cancer therapy. Molecular and Cellular Pharmacology, 2009, 1: 29–43.